These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3535741)
1. Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials. Wilson RE; Wood WC; Lerner HL; Antman K; Amato D; Corson JM; Proppe K; Harmon D; Carey R; Greenberger J Arch Surg; 1986 Nov; 121(11):1354-9. PubMed ID: 3535741 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. Alvegård TA; Sigurdsson H; Mouridsen H; Solheim O; Unsgaard B; Ringborg U; Dahl O; Nordentoft AM; Blomqvist C; Rydholm A J Clin Oncol; 1989 Oct; 7(10):1504-13. PubMed ID: 2674336 [TBL] [Abstract][Full Text] [Related]
3. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups. Antman K; Suit H; Amato D; Corson J; Wood W; Proppe K; Harmon D; Carey R; Greenberger J; Blum R J Clin Oncol; 1984 Jun; 2(6):601-8. PubMed ID: 6374055 [TBL] [Abstract][Full Text] [Related]
4. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials]. Budach V Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407 [No Abstract] [Full Text] [Related]
5. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors. Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for soft-tissue sarcoma: a critical appraisal. Elias AD; Antman KH Semin Surg Oncol; 1988; 4(1):59-65. PubMed ID: 3281213 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. Chang AE; Kinsella T; Glatstein E; Baker AR; Sindelar WF; Lotze MT; Danforth DN; Sugarbaker PH; Lack EE; Steinberg SM J Clin Oncol; 1988 Sep; 6(9):1491-500. PubMed ID: 3047339 [TBL] [Abstract][Full Text] [Related]
9. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Rosenberg SA; Tepper J; Glatstein E; Costa J; Young R; Baker A; Brennan MF; Demoss EV; Seipp C; Sindelar WF; Sugarbaker P; Wesley R Cancer; 1983 Aug; 52(3):424-34. PubMed ID: 6344981 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. Gherlinzoni F; Bacci G; Picci P; Capanna R; Calderoni P; Lorenzi EG; Bernini M; Emiliani E; Barbieri E; Normand A J Clin Oncol; 1986 Apr; 4(4):552-8. PubMed ID: 3514804 [TBL] [Abstract][Full Text] [Related]
11. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947 [TBL] [Abstract][Full Text] [Related]
15. A randomized prospective trial using postoperative adjuvant chemotherapy (adriamycin) in high-grade extremity soft-tissue sarcoma. Eilber FR; Giuliano AE; Huth JF; Morton DL Am J Clin Oncol; 1988 Feb; 11(1):39-45. PubMed ID: 3341273 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT; Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336 [TBL] [Abstract][Full Text] [Related]
17. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472 [TBL] [Abstract][Full Text] [Related]
18. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy in clinical stage M0 sarcoma of soft tissue. de Paula U; Suit HD; Harmon D Cancer; 1988 Nov; 62(9):1907-11. PubMed ID: 3048644 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy of adult patients with soft tissue sarcomas. Rosenberg SA Important Adv Oncol; 1985; ():273-94. PubMed ID: 3916745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]